Overexpression of estrogen receptor-α gene suppresses gap junctional intercellular communication in endometrial carcinoma cells

Oncogene

Volumn 23, Issue 5, 2004, Pages 1109-1116

  Saito, Tsuyoshi ^a   Tanaka, Ryoichi ^a   Wataba, Koya ^a   Kudo, Ryuichi ^a   Yamasaki, Hiroshi ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Cell adhesion; Connexin; Endometrial hyperplasia; Estrogen; Gap junction

Indexed keywords

DEOXYURIDINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GAP JUNCTION PROTEIN; LUCIFER YELLOW;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL COMMUNICATION; CELL GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EXPRESSION VECTOR; GAP JUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HORMONAL CARCINOGENESIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MICROINJECTION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; RECEPTOR INTRINSIC ACTIVITY; TUMOR GROWTH; WESTERN BLOTTING;

CELL COMMUNICATION; CELL DIVISION; CELL LINE, TUMOR; CONNEXINS; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORESCENT DYES; GAP JUNCTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOQUINOLINES; RECEPTORS, ESTROGEN;

PUNCTUM MINUTISSIMUM;

EID: 1442303218     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207215     Document Type: Article

References (60)

1. Al Moustafa AE, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R and Foulkes WD. (2002). Oncogene, 21, 2634-2640.
2. Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S and Dandona P. (2000). Cancer Res., 60, 7094-7098.
3. Anzai Y, Gong Y, Holinka CF, Murphy LJ, Murphy LC, Kuramoto H and Gurpide E. (1992). J. Steroid Biochem. Mol. Biol., 42, 449-455.
4. Ashihara K, Saito T, Mizumoto H, Nishimura M, Tanaka R and Kudo R. (2002). Med. Electron. Microsc., 35, 9-15.
5. Berchuck A and Boyd J. (1995). Cancer, 76, 2034-2040.
6. Darnel AD, Archer TK and Yang K. (1999). J. Steroid Biochem. Mol. Biol., 70, 203-210.
7. Dubina MV, Iatckii NA, Popov DE, Vasil'ev SV and Krutovskikh VA. (2002). Oncogene, 21, 4992-4996.
8. Duggan BD, Felix JC, Muderspach LI, Tourgeman D, Zheng J and Shibata D. (1994). J. Natl. Cancer. Inst., 86, 1216-1221.
9. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S. (1998). Cancer Res., 58, 3526-3528.
10. Grummer R, Traub O and Winterhager E. (1999). Endocrinology, 140, 2509-2516.
11. Hanna EA, Umhauer S, Roshong SL, Piechocki MP, Fernstrom MJ, Fanning JD and Ruch RJ. (1999). Carcinogenesis, 20, 1369-1373.
12. Heikaus S, Winterhager E, Traub O and Grummer R. (2002). J. Mol. Endocrinol., 29, 239-249.
13. Hirai A, Yano T, Nishikawa K, Suzuki K, Asano R, Satoh H, Hagiwara K and Yamasaki H. (2003). Am. J. Nephrol., 23, 172-177.
14. Holinka CF, Hata H, Kuramoto H and Gurpide E. (1986). Cancer Res., 46, 2771-2774.
15. Huang R, Lin Y, Wang CC, Gano J, Lin B, Shi Q, Boynton A, Burke J and Huang RP. (2002). Cancer Res., 62, 2806-2812.
16. Jamil A, Croxtall JD and White JO. (1991). J. Mol. Endocrinol., 6, 215-221.
17. Kamibayashi Y, Oyamada Y, Mori M and Oyamada M. (1995). Carcinogenesis, 16, 1287-1297.
18. Kleinman D, Karas M, Roberts Jr CT, LeRoith D, Phillip M, Segev Y, Levy J and Sharoni Y. (1995). Endocrinology, 136, 2531-2537.
19. Klotz LO, Patak P, Ale-Agha N, Buchczyk DP, Abdelmohsen K, Gerber PA, von Montfort C and Sies H. (2002). Cancer Res., 62, 4922-4928.
20. Kohler MF, Nishii H, Humphrey PA, Saski H, Marks J, Bast RC, Clarke-Pearson DL, Boyd J and Berchuck A. (1993). Am. J. Obstet. Gynecol., 169, 690-694.
21. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A. (1997). Nat. Genet., 17, 143-144.
22. Krutovskikh V and Yamasaki H. (1997). Histol. Histopathol., 12, 761-768.
23. Krutovskikh VA, Oyamada M and Yamasaki H. (1991). Carcinogenesis, 12, 1701-1706.
24. Kurman RJ, Kaminski PF and Norris HJ. (1985). Cancer, 56, 403-412.
25. Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD and Alaoui-Jamali MA. (1999). Cancer Res., 59, 4104-4110.
26. Lee SW, Tomasetto C, Paul D, Keyomarsi K and Sager R. (1992). J. Cell Biol., 118, 1213-1221.
27. Locke D. (1998). J. Pathol., 186, 343-349.
28. Loncarek J, Yamasaki H, Levillain P, Milinkevitch S and Mesnil M. (2003). Mol. Carcinogen., 36, 74-81.
29. Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast Jr RC and Berchuck A. (1994). Cancer, 73, 2380-2385.
30. Mesnil M, Krutovskikh V, Piccoli C, Elfgang C, Traub O, Willecke K and Yamasaki H. (1995). Cancer Res., 55, 629-639.
31. Mizumoto H, Saito T, Ashihara K, Nishimura M, Tanaka R and Kudo R. (2002). Int. J. Cancer, 100, 401-406.
32. Nei H, Saito T, Yamasaki H, Mizumoto H, Ito E and Kudo R. (1999). Mol. Carcinogen., 25, 207-218.
33. Nishida M. (2002). Hum. Cell, 15, 104-117.
34. Nishimura M, Saito T, Yamasaki H and Kudo R. (2003). Carcinogenesis, 24, 1615-1623.
35. Ozog MA, Bechberger JF and Naus CC. (2002). Cancer Res., 62, 3544-3548.
36. Parc YR, Hailing KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN and Hailing AC. (2000). Int. J. Cancer, 86, 60-66.
37. Petrocelli T and Lye SJ. (1993). Endocrinology, 133, 284-290.
38. Risek B, Guthrie S, Kumar N and Gilula NB. (1990). J. Cell Biol., 110, 269-282.
39. Risek B, Klier FG, Phillips A, Hahn DW and Gilula NB. (1995). J. Cell Sci., 108 (Part 3), 1017-1032.
40. Saito T, Barbin A, Omori Y and Yamasaki H. (1997a). Cancer Res., 57, 375-377.
41. Saito T, Nishimura M, Kudo R and Yamasaki H. (2001). Int. J. Cancer, 93, 317-323.
42. Saito T, Oyamada M, Yamasaki H, Mori M and Kudo R. (1997b). Int. J. Cancer, 73, 479-485.
43. Saito T, Schlegel R, Andresson T, Yuge L, Yamamoto M and Yamasaki H. (1998). Oncogene., 17, 1673-1680.
44. Saito T, Schneider A, Martel N, Mizumoto H, Bulgay-Moerschel M, Kudo R and Nakazawa H. (1997c). Biochem. Biophys. Res. Commun., 231, 610-614.
45. Sasaki H, Nishii H, Takahashi H, Tada A, Furusato M, Terashima Y, Siegal GP, Parker SL, Kohler MF and Berchuck A et al. (1993). Cancer Res., 53, 1906-1910.
46. Singal R, Tu ZJ, Vanwert JM, Ginder GD and Kiang DT. (2000). Anticancer Res., 20, 59-64.
47. Southern PJ and Berg P. (1982). J. Mol. Appl. Genet., 1, 327-341.
48. Tan LW, Bianco T and Dobrovic A. (2002). Carcinogenesis, 23, 231-236.
49. Thenot S, Charpin M, Bonnet S and Cavailles V. (1999). Mol. Cell Endocrinol., 156, 85-93.
50. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I and Chambon P. (1989). EMBO J., 8, 1981-1986.
51. Trosko JE and Chang CC. (2001). Mutat. Res., 480-481, 219-229.
52. Trosko JE and Ruch RJ. (1998). Front. Biosci., 3, D208-D236.
53. Trosko JE and Ruch RJ. (2002). Curr. Drug Targets, 3, 465-482.
54. Tsai H, Werber J, Davia MO, Edelman M, Tanaka KE, Melman A, Christ GJ and Geliebter J. (1996). Biochem. Biophys. Res. Commun., 227, 64-69.
55. Wataba K, Saito T, Fukunaka K, Ashihara K, Nishimura M and Kudo R. (2001). Int. J. Cancer, 91, 448-456.
56. Wentz WB. (1974). Gynecol. Oncol., 2, 362-367.
57. Willecke K, Temme A, Teubner B and Ott T. (1999). Ann. NY Acad. Sci., 883, 302-309.
58. Yamasaki H and Naus CC. (1996). Carcinogenesis, 17, 1199-1213.
59. Yamasaki H, Omori Y, Zaidan-Dagli ML, Mironov N, Mesnil M and Krutovskikh V. (1999). Cancer Detect. Prev., 23, 273-279.
60. Zhu D, Caveney S, Kidder GM and Naus CC. (1991). Proc. Natl. Acad. Sci. USA, 88, 1883-1887.